Eye2Gene

Eye2Gene's mission is to help provide a genetic diagnosis for people with sight-loss caused by an inherited retinal dystrophy (IRD) faster than ever before and for everyone in the world. In parallel we support producers of gene therapies to make informed data driven decisions to get their therapies to the right patients at the right time in the safest and most effective way. Over 300 gene mutations are known to cause IRD and a genetic diagnosis is a significant step towards managing, and possibly treating, people's sight-loss. Eye2Gene makes genetic diagnosis faster and more accessible to more IRD-affected families while helping to bring more therapies to market.